SCHEMBL5589825

SCHEMBL5589825

CCCCc1cc(OC(=O)O)c(O)c(-c2ccccc2)c1CCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.41
ESR1 P03372 5/20 0.40
ESR2 Q92731 5/20 0.40
NCEH1 Q6PIU2 1/20 0.39
GCGR P47871 2/20 0.39
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
DPP4 P27487 1/20 0.38
FPR1 P21462 1/20 0.37
DCTPP1 Q9H773 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589810 0.96 CNR2 (0.40) CNR2ESR1ESR2NCEH1PPARG
SCHEMBL5590131 0.94 CNR2 (0.40) CNR2ESR1ESR2GCGRPPARG
SCHEMBL5588532 0.90 CNR2 (0.41) CNR2ESR1ESR2PPARGPPARA
SCHEMBL5589189 0.90 PPARG (0.38) CNR2NCEH1PPARGPPARADPP4
SCHEMBL5588022 0.86 LTB4R (0.38) CNR2ESR1ESR2PPARGPPARA
SCHEMBL5587746 0.83 CNR2 (0.40) CNR2ESR1ESR2NCEH1PPARG
SCHEMBL5587373 0.83 ESR1 (0.40) CNR2ESR1ESR2GCGRKDM4E
SCHEMBL5586756 0.82 CNR2 (0.37) CNR2PPARGPPARAFPR1KDM4E
SCHEMBL5587372 0.81 PPARG (0.40) PPARGPPARAKDM4ENPC1ALDH1A1
SCHEMBL5588358 0.80 PPARG (0.39) PPARGPPARAKDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CNR2 3732/4885ESR1 1108/4885ESR2 2269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.